Literature DB >> 33025599

Integrated network pharmacology and molecular docking strategy to explore the mechanism of medicinal and edible Astragali Radix-Atractylodis Macrocephalae Rhizoma acting on pneumonia via immunomodulation.

Qiguo Wu1,2, Yeqing Hu3.   

Abstract

Pneumonia refers to a death-causing infection. Astragali Radix (AR) and Atractylodis Macrocephalae Rhizoma (AMR) are widely used as traditional tonic and promising edible immunomodulatory herbal medicine, but the systemic mechanism is not well understood. Therefore, a strategy based on network pharmacology and molecular docking was designed to explore the systemic mechanism of AR-AMR acting on pneumonia. After a series of bioinformatics assays, seven kernel targets were obtained, including TNF, IL6, IFNG, IL1B, IL10, IL4, and TLR9. And seven key compounds were identified as the synergy components of AR-AMR acting on pneumonia, the four key compounds belonging to AR were (3R)-3-(2-hydroxy-3,4-dimethoxyphenyl)-7-chromanol, formononetin, quercetin, and kaempferol, the three key compounds belonging to AMR were atractylone, 14-acetyl-12-senecioyl-2E, 8E, 10E-atractylentriol, and α-Amyrin. The crucial pathways were mainly related to three modules, including immune diseases, infectious disease, and organismal systems. Collectively, these observations strongly suggest that the molecular mechanisms of AR-AMR regulating pneumonia were closely related to the correlation between inflammation and immune response. PRACTICAL APPLICATIONS: Astragali radix and Atractylodis macrocephalae rhizoma can be used as "medicine-food homology" for dietary supplement. AR and AMR are widely used as a traditional tonic and promising edible immunomodulatory herbal medicine. The AR-AMR herb pairs are used for compatibility many times in the recommended prescriptions in COVID-19 develop pneumonia in China. However, the ingredients and mechanisms of AR-AMR acting on Pneumonia via immunomodulation are unclear. In this paper, bioinformatics and network biology were used to systematically explore the mechanisms of the AR-AMR herb pairs in treatment of pneumonia, and further analyze the correlation mechanism between it and COVID-19 develop pneumonia. To sum up, our study reveals the interrelationships between components, targets, and corresponding biological processes of AR-AMR acting on pneumonia. Understanding these relationships may provide guidance and theoretical basis for the further application of AR-AMR herb pairs.
© 2020 Wiley Periodicals LLC.

Entities:  

Keywords:  Astragali radix; Atractylodis macrocephalae rhizome; immune; inflammation; molecular docking; network pharmacology; pneumonia

Year:  2020        PMID: 33025599     DOI: 10.1111/jfbc.13510

Source DB:  PubMed          Journal:  J Food Biochem        ISSN: 0145-8884            Impact factor:   2.720


  4 in total

Review 1.  Astragalus mongholicus Bunge (Fabaceae): Bioactive Compounds and Potential Therapeutic Mechanisms Against Alzheimer's Disease.

Authors:  Qianyu Dong; Zhen Li; Qian Zhang; Yueyu Hu; Huazheng Liang; Lize Xiong
Journal:  Front Pharmacol       Date:  2022-06-28       Impact factor: 5.988

2.  The Pharmacological Mechanism of the Effect of Plant Extract Compound Drugs on Cancer Pain Based on Network Pharmacology.

Authors:  Yuanyuan Shen; Jun Wang; Pengpeng Yan; Tiantian Chen; Xingrui Li; Ming Jiang
Journal:  J Healthc Eng       Date:  2022-02-27       Impact factor: 2.682

Review 3.  Antiosteoporosis Studies of 20 Medicine Food Homology Plants Containing Quercetin, Rutin, and Kaempferol: TCM Characteristics, In Vivo and In Vitro Activities, Potential Mechanisms, and Food Functions.

Authors:  Dayue Shen; Yating Feng; Xilan Zhang; Le Gong; Jing Liu; Yuanping Li; Hui Liao
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-31       Impact factor: 2.629

4.  Yishen Huashi Granules Ameliorated the Development of Diabetic Nephropathy by Reducing the Damage of Glomerular Filtration Barrier.

Authors:  Tingting Zhao; Minyi Li; Qian Xiang; Beifeng Lie; Deqi Chen; Weiming Wang; Xuling Li; Tiancheng Xu; Xi Zhang; Yuntong Li; Ruixue Dong; Xinwen Du; Yilin Wang; Junzheng Yang; Bao He; Quan Zhu; Tingting Duan; Zhenghai Li; Youhua Xu
Journal:  Front Pharmacol       Date:  2022-07-22       Impact factor: 5.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.